You’re framing this as if people are ignoring risk, when actually it’s a comparison of risks.
Yes, long term data specifically for weight loss use is still developing, but we do have several years of trial data, plus much longer term use in diabetes & so far there’s no signal of widespread serious harm. The mechanism of these drugs is the same in both groups (they act on GLP1 receptors affecting appetite, satiety & insulin response). So the data we have from diabetics is is still highly relevant in understanding safety, even if the initial aim for taking it aren’t identical.
Pancreatitis is linked to rapid weight loss (as we’ve discussed already) so the risk isn’t going to increase with long term use as your weight loss will naturally slow down over time, even if it is rapid to start.
The risks of weight regain after obesity are very well established and affect a large proportion of people. That’s why people will choose to stay on WLIs indefinitely. They know they need them. The incidence of regain after weight loss without WLIs is huge too, so the choice for many is stay on them
or stay fat. And given the very well documented risks of obesity, is a no brainier.
Some of the concerns you’ve raised, like muscle or bone loss, are also associated with weight loss in general. They can be prevented with adequate nutrition & resistance training - both things that are easier when you are a healthy weight.
Side effects like nausea are also usually temporary. People who don’t tolerate the drugs don’t tend to stay on them long term.
The comparisons you’ve made to things like SSRIs or PPIs actually reinforce the point…plenty of medications have known long-term risks, and people still take them because the benefits outweigh those risks. That’s the same calculation happening here.
Also, “losing 7/8ths of her hair” feels like a bit of an exaggeration. That would mean almost total hair loss, which isn’t something that’s been reported with these medications.
Hair loss can happen with significant weight loss from any cause & it’s usually temporary. Given you’ve said your friend has a long history of severe eating disorders, it’d be a bit harder to attribute any side effects to GLP1s. I completely agree she shouldn’t have access though, you are asked very clearly in the screening questionnaires if you have had an eating disorder. Lying to obtain drugs is obviously an issue - but she has to take some personal responsibility there & isn’t evidence that the drug is dangerous - just further evidence of making it available via your doctor.
Lastly, when you say “you could Google it”. We are. We have. But we don’t come to the same conclusion as you. The studies don’t show the data you hope they do (ie progressively more risky the longer you’re on it) & most of us know that the alternative is going back to our old lives.